Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 7, 2018

View Archived Issues

Retinoic acid has role in fragile X

RNA delivery improves CF symptoms

miRNA-126 and miRNA-223 found significantly increased in cardiac sarcoidosis

Hypermethylation variant silences BRCA1 gene

Upregulation of transgelin-2 by KRAS gene mutation contributes to pancreatic cancer development

Almac, Elasmogen and Innovate UK to develop VNAR-based oncology platform

Final results from PROPEL study support further clinical development of PTG-100 in UC

MediciNova, University of Cambridge to study ibudilast in degenerative cervical myelopathy

Researchers discover potent and selective histone deacetylase 11 inhibitors

First patient treated in phase I of HPN-424 in metastatic castration-resistant prostate cancer

Ovid Therapeutics reports topline data from STARS study in Angelman syndrome

Topical curcumin nanocarriers provide retinal protection in preclinical eye disease models

Aevitas Therapeutics, University of Pennsylvania enter sponsored research agreement

Mebias Discovery patents new compounds for pain

Lundbeck's Lu-AF82422 for Parkinson's enters the clinic

Japanese researchers synthesize new analgesic drugs

Angiochem reaches agreement on design of phase III study of ANG-1005

Novel long-range PCR method allows Ebola virus genome sequencing from ecological or clinical samples

NanoViricides' topical dermal shingles drug candidates show efficacy in rat model

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...